Hormel
HRL
$24.44
+0.62%
Hormel Foods Corporation is a leading branded food company operating in the Consumer Defensive sector, specifically within the Packaged Foods industry. Historically meat-focused, the company has broadened its portfolio to include a wide range of protein offerings and shelf-stable products, with major brands like Spam, Jennie-O, Applegate, Planters, and Skippy. It holds a dominant market position, with many of its brands ranking number one or two in their respective categories, making it a staple consumer goods player. The current investor narrative centers on a potential turnaround, driven by strategic divestitures of volatile business units, recent earnings beats, and margin expansion despite ongoing cost pressures, as the company seeks to pivot towards more stable, value-added growth.…
HRL
Hormel
$24.44
Related headlines
Investment Opinion: Should I buy HRL Today?
Rating: Hold. The core thesis is that HRL is a compelling but unproven turnaround story; investors should wait for evidence of sustained execution before committing capital, as the current price already reflects much of the near-term optimism from the Q1 beat.
Supporting this view are several data points: 1) The forward P/E of 14.9x is reasonable but not a deep discount, requiring earnings to meet the $1.68 EPS estimate. 2) Revenue growth is stagnant at 1.3% YoY, offering no top-line tailwind. 3) Profitability is volatile, with a net loss in Q4 2025 preceding the Q1 profit. 4) While free cash flow is strong at $577.5M, it is being consumed by an unsustainable dividend payout ratio of 132%. The stock's 11% monthly rally suggests the market is beginning to price in a recovery, leaving limited margin of safety.
The thesis would upgrade to a Buy if the company demonstrates sequential revenue growth above 3% and stabilizes gross margins above 16% for two consecutive quarters, confirming the turnaround. It would downgrade to a Sell if the stock breaks below $19.70 support on failed earnings or if the dividend payout ratio remains above 100% while earnings stagnate. Relative to its history and the challenged fundamentals, the stock appears fairly valued, trading between the hope of a recovery and the reality of stagnant operations.
Sign up to view all
HRL 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The data paints a picture of a company with significant strengths (brands, FCF, balance sheet) but profound weaknesses (no growth, margin pressure). The recent earnings beat is a positive step, but it is insufficient to declare a sustained turnaround. The stock is fairly valued for this uncertain phase. The stance would upgrade to bullish on evidence of two consecutive quarters of margin expansion and revenue growth above 3%. It would downgrade to bearish on a break below $19.70 or a dividend cut, either of which would signal the turnaround has failed.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hormel's 12-month outlook, with a consensus price target around $31.77 and implied upside of +30.0% versus the current price.
Average Target
$31.77
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$20 - $32
Analyst target range
Analyst coverage is limited, with only 4 analysts providing estimates, indicating this large-cap stock may have waning institutional interest. The consensus sentiment appears mixed, as recent institutional ratings include a 'Buy' from Goldman Sachs, an 'Overweight' from JP Morgan and Barclays, and 'Neutral' or 'Equal Weight' ratings from B of A Securities, Piper Sandler, and Stephens & Co., reflecting uncertainty about the pace and sustainability of a turnaround. The average revenue estimate for the next period is approximately $12.76 billion, with a tight range between $12.76B and $12.77B, while the average EPS estimate is $1.68, ranging from $1.58 to $1.79; however, without a published consensus price target, the implied upside or downside cannot be calculated, underscoring the lack of clear directional conviction from the analyst community.
Bulls vs Bears: HRL Investment Factors
The evidence presents a classic turnaround versus value trap debate. The bear case currently holds stronger evidence, anchored by a 24% annual price decline, stagnant revenue, and margin compression that justify the market's skepticism. However, the bull case is gaining traction with a concrete catalyst: a strong Q1 earnings beat, a return to profitability, and strategic divestitures. The single most important tension is whether the Q1 2026 results mark a sustainable inflection in profitability and growth, or merely a temporary bounce within a longer-term decline. The resolution hinges on the company's ability to translate its strong free cash flow and strategic focus into consistent top-line expansion and margin stabilization over the next several quarters.
Bullish
- Strong Earnings Beat & Turnaround Signal: The recent Q1 2026 earnings beat and return to profitability ($181.77M net income vs. a loss in Q4 2025) triggered a sharp 11.28% monthly rally, signaling a potential inflection point. Management's reaffirmed full-year outlook suggests confidence in the strategic pivot towards more stable, value-added growth.
- Robust Financial Flexibility: A strong balance sheet with a current ratio of 2.47 and manageable debt-to-equity of 0.36 provides a significant buffer. Robust TTM free cash flow of $577.53M offers ample liquidity to fund the dividend and strategic initiatives without financial stress.
- Attractive Forward Valuation: The forward P/E of 14.92x represents a substantial discount to the trailing P/E of 27.31x, pricing in a significant earnings recovery. This forward multiple is more in line with sector norms, suggesting the stock is not overvalued if the turnaround materializes.
- Defensive Profile & Dividend Yield: A low beta of 0.313 and a 4.85% dividend yield offer defensive characteristics in volatile markets. The company's dominant brand portfolio (Spam, Jennie-O, Planters) provides a stable revenue base, with many brands holding #1 or #2 market share.
Bearish
- Severe Long-Term Underperformance: The stock is down 24.14% over the past year and trades near multi-year lows, representing a -51.18% relative strength loss versus the S&P 500. This entrenched downtrend indicates deep-seated investor pessimism that a single earnings beat may not reverse.
- Stagnant Revenue & Margin Pressure: Revenue growth is anemic at 1.29% YoY, with quarterly revenue essentially flat for two years. Gross margin compression from 16.91% a year ago to 15.61% in Q1 2026 highlights persistent cost pressures and pricing challenges.
- Elevated Trailing P/E & High Payout: A trailing P/E of 27.31x is elevated for a company with flat growth and margin pressure, suggesting the stock is not cheap on current earnings. The dividend payout ratio of 132.41% based on trailing earnings is unsustainable without a swift earnings recovery.
- Limited Analyst Conviction: Only 4 analysts provide estimates, and there is no published consensus price target, indicating waning institutional interest and a lack of clear directional conviction. The mixed ratings (Buy, Overweight, Neutral) reflect uncertainty about the turnaround's sustainability.
HRL Technical Analysis
The stock is entrenched in a pronounced downtrend, with a 1-year price change of -24.14% and a current price of $23.29, which is near the bottom of its 52-week range of $19.70 to $31.86. This positions the stock at approximately 32% of its 52-week range, indicating it is trading near multi-year lows and may represent a deep-value opportunity, though it also signals significant negative momentum and investor pessimism. Recent momentum shows a sharp but volatile recovery attempt, with the stock up 11.28% over the past month, which contrasts starkly with its 3-month decline of -4.63%; this divergence suggests a potential short-term oversold bounce or reaction to positive earnings news, but it has yet to establish a sustained reversal against the powerful longer-term downtrend. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $31.86 and critical support at the 52-week low of $19.70; a sustained break below $19.70 would signal a continuation of the bearish trend, while reclaiming the $25 level could suggest a more durable recovery is underway. The stock's low beta of 0.313 indicates it is approximately 69% less volatile than the broader market (SPY), which has gained 27.04% over the past year, highlighting its defensive nature but also its significant underperformance and weak relative strength of -51.18% over the same period.
Beta
0.34
0.34x market volatility
Max Drawdown
-37.4%
Largest decline past year
52-Week Range
$20-$32
Price range past year
Annual Return
-21.0%
Cumulative gain past year
| Period | HRL Return | S&P 500 |
|---|---|---|
| 1m | +21.1% | -0.1% |
| 3m | +8.0% | +11.4% |
| 6m | +1.6% | +8.2% |
| 1y | -21.0% | +22.7% |
| ytd | +4.5% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HRL Fundamental Analysis
Revenue growth is anemic, with the most recent quarterly revenue of $3.03 billion representing a modest year-over-year increase of 1.29%; the multi-quarter trend shows revenue has been essentially flat, hovering between $2.89 billion and $3.19 billion over the last eight quarters, indicating a mature business struggling for top-line expansion. Profitability is under pressure, as evidenced by a net income of $181.77 million in the latest quarter and a gross margin of 15.61%, which is down from 16.91% a year prior; however, the company returned to profitability in Q1 2026 after a significant net loss of -$56.14 million in Q4 2025, suggesting potential stabilization, though operating margins remain thin at 5.94%. The balance sheet and cash flow position remain a relative strength, with a healthy current ratio of 2.47, a manageable debt-to-equity ratio of 0.36, and robust trailing twelve-month free cash flow of $577.53 million, which provides ample liquidity to fund the dividend (payout ratio of 132.41% based on trailing earnings) and navigate the current operational challenges without external financing stress.
Quarterly Revenue
$3.0B
2026-01
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$577532000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HRL Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 27.31x, while the forward PE is significantly lower at 14.92x, indicating the market expects a substantial earnings recovery in the coming year, likely pricing in the recent return to profitability and strategic initiatives. Compared to sector averages, Hormel's trailing PE of 27.31x is likely at a premium to many packaged food peers, which often trade in the low-20s, though a direct industry average is not provided in the data; this premium may reflect its strong brand portfolio and dividend history, but is difficult to justify given its stagnant growth and margin compression. Historically, the stock's own valuation has compressed dramatically from a trailing PE above 30x in early 2023 to its current level near 27x; while this is below its recent historical highs, it remains above the lows seen during its profitable quarters in 2024 (around 19x-22x), suggesting the stock is not at a deep historical discount despite its significant price decline, as earnings have fallen faster than the share price.
PE
27.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -58x~36x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on profitability and dividend sustainability. Despite a return to profit in Q1 2026, gross margins have compressed 130 basis points YoY to 15.61%, and operating margins are thin at 5.94%. The dividend, with a 4.85% yield, is supported by a payout ratio of 132% based on trailing earnings, which is unsustainable without a swift and durable earnings recovery. Revenue concentration is another concern, with 73% of sales from perishable foods, exposing the company to commodity price volatility and supply chain disruptions, as seen in the historic cattle shortage driving record beef prices.
Market & Competitive Risks are dominated by valuation compression. The stock's trailing P/E of 27.3x is likely at a premium to many packaged food peers, yet the company lacks the growth to justify it. Its low beta of 0.313, while defensive, has correlated with severe underperformance (-51% relative strength), indicating a sector rotation away from stagnant consumer staples. Competitive and regulatory pressures in the packaged food industry could further squeeze already-thin margins, limiting pricing power.
The Worst-Case Scenario involves the Q1 earnings beat proving to be a head-fake. If revenue growth remains flat and margins fail to recover, earnings estimates would be cut, calling the dividend into question and triggering multiple compression. This could see the stock re-test and break its 52-week low of $19.70. From the current price of ~$23.29, this implies a realistic downside of approximately -15%. A more severe scenario, factoring in a dividend cut and a return to losses, could see the stock approach levels implied by its historical P/E lows during profitable quarters (around 19x), suggesting a potential downside of -25% to -30%.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Failure to stabilize or expand gross margins from the current 15.6%, leading to further earnings volatility. 2) Dividend Risk: The unsustainable 132% payout ratio could force a dividend cut, a major negative catalyst for income investors. 3) Growth Risk: Persistent revenue stagnation (1.3% YoY growth) limits upside and could lead to multiple compression. 4) Sentiment Risk: The stock is in a severe downtrend with -51% relative strength; a break below $19.70 support could trigger another wave of selling.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $22 and $26 as the turnaround progresses slowly, with EPS meeting the $1.68 estimate. The Bull Case (25% probability) targets $28 to $31.86 on successful execution and margin expansion. The Bear Case (15% probability) warns of a drop to the $19.70 - $21.00 range if the recovery falters and the dividend is cut. The Base Case is most likely, implying a relatively narrow trading range with modest upside from current levels, contingent on no further operational setbacks.
HRL sends mixed valuation signals. Its trailing P/E of 27.3x appears overvalued given its flat growth and margin compression. However, its forward P/E of 14.9x is more reasonable and suggests the market expects a significant earnings recovery. Compared to sector peers, it is not clearly cheap or expensive. The valuation implies the market is paying a fair price for a company that is expected to stop deteriorating and begin a slow recovery, but is not pricing in robust growth. It is fairly valued relative to its uncertain prospects.
HRL is a speculative buy for investors with a high risk tolerance and a long-term horizon who believe in the management turnaround story. The 4.85% dividend yield and low beta are attractive, but these are offset by stagnant revenue growth and margin pressure. The recent 11% rally on earnings news may have captured near-term upside, leaving limited margin of safety. It could be a good buy for contrarians if purchased on a pullback towards $22, but most investors should wait for more consistent evidence of operational improvement before committing capital.
HRL is unsuitable for short-term trading due to its low beta (0.313) and lack of near-term growth catalysts; its recent pop may be a short-term oversold bounce, not a trend reversal. It is best considered a long-term, income-oriented holding for investors willing to wait 3-5 years for a potential turnaround to fully play out. The high dividend provides compensation during the wait, but the stock requires patience. A minimum holding period of 18-24 months is suggested to assess whether the strategic initiatives are bearing fruit.